[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE